Scienture Holdings Inc
SCNX0.800USD
-0.018-2.21%
Market hours （ET）Quotes delayed by 15 min
12.91MMarket Cap
LossP/E TTM
More Details of Scienture Holdings Inc Company
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Scienture Holdings Inc Info
Ticker SymbolSCNX
Company nameScienture Holdings Inc
IPO dateFeb 18, 2020
CEODr. Narasimhan Mani
Number of employees14
Security typeOrdinary Share
Fiscal year-endFeb 18
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolSCNX
IPO dateFeb 18, 2020
CEODr. Narasimhan Mani
Company Executives of Scienture Holdings Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
2.45M
+72.77%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
50.00K
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
2.45M
+72.77%
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
199.87K
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
50.00K
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Revenue Breakdown
FY2025Q2
FY2025Q1
FY2024
No Data
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Mon, Oct 27
Updated: Mon, Oct 27
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Hariharan (Shankar Ph.D.)
10.60%
Mani (Narasimhan)
7.65%
L1 Capital Global Opportunities Master Fund Ltd.
3.36%
Doshi (Mayur Mansukhlal)
1.33%
Fell (Donald G.)
1.02%
Other
76.03%
Shareholders
Shareholders
Proportion
Hariharan (Shankar Ph.D.)
10.60%
Mani (Narasimhan)
7.65%
L1 Capital Global Opportunities Master Fund Ltd.
3.36%
Doshi (Mayur Mansukhlal)
1.33%
Fell (Donald G.)
1.02%
Other
76.03%
Shareholder Types
Shareholders
Proportion
Individual Investor
21.39%
Corporation
3.36%
Hedge Fund
0.53%
Investment Advisor
0.18%
Investment Advisor/Hedge Fund
0.09%
Other
74.45%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
22
322.69K
6.06%
+99.41K
2025Q2
28
4.45M
32.07%
+469.00
2025Q1
32
4.45M
33.93%
+9.47K
2024Q4
36
4.62M
68.10%
+3.89M
2024Q3
36
1.01M
65.38%
+269.18K
2024Q2
37
1.00M
67.44%
+530.62K
2024Q1
34
476.38K
36.25%
+95.67K
2023Q4
35
386.59K
47.32%
+20.29K
2023Q3
38
376.26K
55.40%
-6.85K
2023Q2
38
402.57K
59.37%
+44.99K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Hariharan (Shankar Ph.D.)
2.37M
11.22%
--
--
Jan 27, 2025
Mani (Narasimhan)
1.42M
6.7%
--
--
Jan 27, 2025
L1 Capital Global Opportunities Master Fund Ltd.
1.07M
5.09%
+1.07M
--
Aug 15, 2025
Doshi (Mayur Mansukhlal)
66.45K
0.31%
--
--
Jan 27, 2025
Fell (Donald G.)
35.16K
0.17%
--
--
Jan 27, 2025
Scoggin Management LP
150.00K
0.71%
+150.00K
--
Aug 14, 2025
Commonwealth Financial Network
43.80K
0.21%
+43.80K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
28.68K
0.14%
-3.48K
-10.83%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Date
Type
Ratio
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
Jun 21, 2023
Merger
15→1
